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See related article on page 374. Bolooki and colleagues1 describe their 22-year experience repairingleft ventricular (LV) aneurysms using 3 surgical techniques thatwere introduced sequentially, with the technique used in group 3being introduced most recently in 1992. During those 22 years,much has changed in the management of patients with heart failureand in cardiac surgery in general. Routine use of angiotensin-
converting enzyme inhibitors and implantable cardioverter-defibrillators started
after the initiation of their study.2,3 The addition of -blockers, spironolactones, and
biventricular synchronous pacing was introduced during the 1990s.4-6 These inter-
ventions for heart failure have had a significant positive effect on the short-term and
midterm prognoses for patients.7 Therefore, it is no surprise that the midterm
survival for their most recent patients is better than that for the patients who
underwent surgical intervention at an earlier time (groups 1 and 2).
Was the improvement in survival in group 3 patients as described by Bolooki and
colleagues the result of the concept of surgical intervention being inherently better
than in the techniques used in group 1 and 2 patients? Although they imply that their
results are better, “especially with endoventricular patch technique,”1 with so many
other changes evolving during the same time, this is a classic apples and oranges
comparison. Unfortunately, no amount of statistical matching would be able to
account for the evolution of medical therapy during this period. Furthermore, the
patients’ pathologies were different, which could make a crucial difference in late
outcomes. The group 3 patients were chosen for this procedure because of minimal
involvement of the septal wall; therefore these patients had a more localized infarct
than those who had a “large dyskinetic septal scar” (group 2). Also, there are no data
to compare ventricular volumes or even dimensions to allow more meaningful
comparison between the groups. Therefore, with the evolution of medical therapies
and different populations, it is not surprising that group 3 patients achieved better
5-year survival, and this cannot be attributed to the surgical technique.
What is surprising is that there was no improvement in perioperative mortality in
the more recent group compared with in the groups that began to be treated in 1979.
Surgical procedures also evolved during the past 2 decades, with changes such as
more effective techniques of cardioplegia, intraoperative echocardiography, and the
availability of new inotropic drugs, such as phosphodiesterase inhibitors.8 Most
surgeons think that surgical intervention is safer today than it was 22 years ago.
Also, the operative mortality in this report is high compared with modern stan-
dards.9-11 The high mortality probably relates to the inclusion of patients with
cardiogenic shock as an indication for surgical intervention. The operative mortality
for this group of patients was 46%, and the 3-year survival was 36%. No informa-
tion was given regarding late functional outcome of the patients with cardiogenic
shock. Were those patients still limited by heart failure? There are broadly 2
scenarios in which a patient with an aneurysm would experience shock: an acute
infarction in a vessel remote from the aneurysm or progressive disease that has
caused remote muscle to fail. If a patient has an aneurysm and then infarction occurs
in another vessel, there might be little remaining viable myocardium to support
cardiac function. Similarly, if remote areas of muscle are so dysfunctional that the
patient experiences shock, there are some problems that conventional cardiac
surgery cannot reliably reverse. From these data, it seems that patients with LV
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aneurysms in cardiogenic shock pose one of those problems.
Unconventional approaches might be needed in this case,
such as mechanical support or transplantation.
Because ventricular dilatation caused by the aneurysm
leads to apical displacement of the papillary muscles and
functional mitral regurgitation, it is also surprising in this
series that mitral valve surgery was rarely used. Mitral
regurgitation leads to LV volume overload and might cause
late deleterious ventricular remodeling, which is improved
with mitral repair.12-15 An additional surgical point relates
to the size of the remaining LV cavity and the patch. In
general, a small patch and smaller LV volumes should lead
to a good outcome (group 3 in the series by Bolooki and
colleagues1) unless ventricular volumes are so low that
diastolic dysfunction might be created or mitral regurgita-
tion might be increased by distortion of the papillary mus-
cles.15,16 We have avoided using a patch reconstruction in
more than 95% of patients, however, by using a double-
cerclage technique with ventriculoplasty.11 Because replac-
ing a dyskinetic aneurysm with an akinetic patch seems to
result in only limited success, we hope that reconstruction
without akinetic prosthetic material will lead to better late
outcomes. We do not know from this article what the size of
the left ventricle was before or after patch repair or whether
mitral regurgitation developed after reconstruction.
Bolooki and colleagues,1 at the end of their article, make
a case for the surgical treatment for ischemic heart failure
trial, a randomized surgical trial to help determine the
benefits of LV reconstruction, and coronary bypass in this
era of improving medical therapies for patients with heart
failure. However, should surgeons randomize patients with
LV aneurysms, an operation we have been performing suc-
cessfully since 1958, because medicines have shown short-
term and midterm improvement in patients with heart fail-
ure? I think not. Those trials largely excluded patients with
“surgical problems,” such as aneurysms or extensive coro-
nary disease with ischemia. Therefore, the results of the
medical trials might not apply to a patient population with
classic surgical indications. LV aneurysms are mechanical
problems that increase wall stress and myocardial oxygen
consumption, activate neurohormones, and decrease myo-
cardial efficiency.17,18 Mathematic modeling and clinical
studies show improvement in remote muscle function after
aneurysm repair.19,20 Medications might palliate heart fail-
ure, but an untreated mechanical problem will lead to poor
long-term effectiveness. Because medical therapy has im-
proved does not mean that we need to rethink all our
strategies about surgical intervention. Should we randomize
patients with aortic stenosis and severe LV dysfunction to
medical therapy? No, because there is an underlying me-
chanical problem that will not be addressed by medica-
tion.21 A much smaller trial to determine the benefit of LV
reconstruction for akinetic areas (not aneurysms) might be
more useful. Akinetic areas create less of a mechanical
problem than true aneurysms, the scar and muscle are het-
erogeneous, and clinical results are more equivocal.20,22
Would coronary artery bypass grafting with reconstruction
of an akinetic ventricle be better than coronary artery bypass
grafting alone? That would be an important clinical question
for a trial. Unlike coronary artery bypass trials, however,
this surgical trial is much more difficult because of the
complex issues of patient selection, preoperative imaging,
intraoperative management (patch versus no patch, manage-
ment of mitral regurgitation, and extent of LV reconstruc-
tion), perioperative care, and follow-up in designated heart
failure centers. An international trial to investigate this
complex strategy will face many obstacles.
In summary, the reconstruction technique described in
group 3 might yield better late results. However, this study
does not prove this claim because the patients were signif-
icantly different at baseline, and over time, there was a
revolution in the treatment of patients with heart failure.
This study did demonstrate that LV aneurysm repair is not
a very successful strategy for patients with cardiogenic
shock. Finally, for patients undergoing surgical intervention
for heart failure, late follow-up studies might be of only
limited benefit. Like the stock market, past results might not
indicate future results. However, with better patient selec-
tion, preoperative imaging, perioperative management, and
synergistic management of heart failure with our colleagues
in cardiology, we should be entering a bull market in the
surgical treatment of patients with heart failure.
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